Carna Biosciences, Inc.
Clinical-stage biopharma developing small molecule kinase inhibitors.
4572 | T
Overview
Corporate Details
- ISIN(s):
- JP3220550002
- LEI:
- Country:
- Japan
- Address:
- 神戸市中央区港島南町一丁目５番５号
- Website:
- https://www.carnabio.com/
- Sector:
- Manufacturing
Description
Carna Biosciences, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of small molecule kinase inhibitors. The company focuses on creating therapies for diseases with significant unmet medical needs, particularly in oncology and autoimmune disorders. Carna Biosciences operates through two core segments: a drug discovery business that advances its proprietary pipeline of drug candidates, and a drug discovery support business. The support division provides the global research community with a comprehensive portfolio of products and services, including a wide array of kinase proteins, biochemical and cell-based screening, and profiling services to accelerate pharmaceutical research and development.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-26 02:36 |
有価証券報告書－第18期(令和2年1月1日－令和2年12月31日)
|
Japanese | 1.2 MB | ||
| 2020-11-10 02:22 |
四半期報告書－第18期第3四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | 164.0 KB | ||
| 2020-08-11 02:57 |
四半期報告書－第18期第2四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | 200.9 KB | ||
| 2020-05-13 03:02 |
四半期報告書－第18期第1四半期(令和2年1月1日－令和2年3月31日)
|
Japanese | 164.7 KB | ||
| 2020-03-27 02:45 |
有価証券報告書－第17期(平成31年1月1日－令和1年12月31日)
|
Japanese | 1.3 MB | ||
| 2019-11-11 02:01 |
四半期報告書－第17期第3四半期(2019/07/01－2019/09/30)
|
Japanese | 197.1 KB | ||
| 2019-08-14 02:57 |
四半期報告書－第17期第2四半期(2019/04/01－2019/06/30)
|
Japanese | 235.8 KB | ||
| 2019-05-14 03:08 |
四半期報告書－第17期第1四半期(2019/01/01－2019/03/31)
|
Japanese | 160.3 KB | ||
| 2019-03-27 01:35 |
有価証券報告書－第16期(平成30年1月1日－平成30年12月31日)
|
Japanese | 1.2 MB | ||
| 2018-11-12 02:09 |
四半期報告書－第16期第3四半期(2018/07/01－2018/09/30)
|
Japanese | 150.7 KB | ||
| 2018-08-07 02:02 |
四半期報告書－第16期第2四半期(2018/04/01－2018/06/30)
|
Japanese | 176.3 KB | ||
| 2018-05-14 02:57 |
四半期報告書－第16期第1四半期(2018/01/01－2018/03/31)
|
Japanese | 139.3 KB | ||
| 2018-03-29 03:01 |
有価証券報告書－第15期(平成29年1月1日－平成29年12月31日)
|
Japanese | 1.1 MB | ||
| 2017-11-13 02:56 |
四半期報告書－第15期第3四半期(2017/07/01－2017/09/30)
|
Japanese | 203.3 KB | ||
| 2017-08-08 03:11 |
四半期報告書－第15期第2四半期(2017/04/01－2017/06/30)
|
Japanese | 217.3 KB |
Automate Your Workflow. Get a real-time feed of all Carna Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Carna Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Carna Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
